GeneMatrix

GeneMatrix is a South Korean company that provides molecular diagnostic services. Its main service involves diagnosing DNA mutations based on its proprietary Restriction Fragment Mass Polymorphism (RFMP) technology. Genematrix’s molecular diagnostic technologies, including C-TAG, Omniplex, EnCleap, TriO, and REMP, are used for diseases such as hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections, which can be detected through molecular diagnostic methods. In particular, we have become a leading company in the global market by securing our original technology with multiple advantages worldwide. This technology allows the simultaneous detection of multiple genes or pathogens in a single test.